Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic prophylaxis in inguinal or femoral hernia repair
2023-507319-36-00Phase 3Authorised
- Sponsor
- Hospital Universitario de Móstoles
- Start
- Feb 2024
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in inguinal hernia and femoral hernia comparing Cefazolin prophylaxis with Placebo / no prophylaxis (2 arms). Primary endpoint: Necessity of antibiotic prophylaxis in inguinal and femoral hernia repair. Planned start Feb 2024; status: authorised.
02
Drugs
cefazolin
03
Conditions
inguinal herniafemoral hernia
Beyond the preview
Go deeper on 2023-507319-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-507319-36-00.